NEW COLLABORATION TO PROVIDE ENHANCED DRUG DISCOVERY AND DEVELOPMENT SERVICES FOR UK PHARMA, BIOTECH AND ACADEMIA

摘要

Two UK companies have announced a collaborative service offering aligned to biotech, pharma and academic institutes, that promises to simplify the transition from drug discovery to development, scale-up and commercialisation. Johnson Matthey Fine Chemicals, a leading provider of pharmaceutical services, APIs and catalyst technologies, and Domainex, a small-molecule drug discovery company, will together provide integrated small molecule pharmaceutical discovery and development services from their facilities based in Cambridge, UK.